102 related articles for article (PubMed ID: 9449399)
21. An in vivo and in vitro study of the mechanism of prednisone-induced insulin resistance in healthy subjects.
Pagano G; Cavallo-Perin P; Cassader M; Bruno A; Ozzello A; Masciola P; Dall'omo AM; Imbimbo B
J Clin Invest; 1983 Nov; 72(5):1814-20. PubMed ID: 6355186
[TBL] [Abstract][Full Text] [Related]
22. Angiotensin II enhances insulin-stimulated whole-body glucose disposal but impairs insulin-induced capillary recruitment in healthy volunteers.
Jonk AM; Houben AJ; Schaper NC; de Leeuw PW; Serné EH; Smulders YM; Stehouwer CD
J Clin Endocrinol Metab; 2010 Aug; 95(8):3901-8. PubMed ID: 20501681
[TBL] [Abstract][Full Text] [Related]
23. The effect of urapidil on responses to phenylephrine, angiotensin and isoprenaline in man.
Tomlinson B; Renondin JC; Graham BR; Prichard BN
Eur J Clin Pharmacol; 1991; 41(1):1-3. PubMed ID: 1685992
[TBL] [Abstract][Full Text] [Related]
24. The effect of glimepiride on pancreatic beta-cell function under hyperglycaemic clamp and hyperinsulinaemic, euglycaemic clamp conditions in non-insulin-dependent diabetes mellitus.
Clark HE; Matthews DR
Horm Metab Res; 1996 Sep; 28(9):445-50. PubMed ID: 8911981
[TBL] [Abstract][Full Text] [Related]
25. Adrenoceptor-mediated control of glucose homeostasis in obese hyperglycaemic (ob/ob) mice.
Bailey CJ; Flatt PR
Diabetes Res; 1990 Jun; 14(2):87-91. PubMed ID: 1966872
[TBL] [Abstract][Full Text] [Related]
26. Insulin modulation of an endothelial nitric oxide component present in the alpha2- and beta-adrenergic responses in human forearm.
Lembo G; Iaccarino G; Vecchione C; Barbato E; Izzo R; Fontana D; Trimarco B
J Clin Invest; 1997 Oct; 100(8):2007-14. PubMed ID: 9329964
[TBL] [Abstract][Full Text] [Related]
27. Low-dose angiotensin II increases glucose disposal rate during euglycemic hyperinsulinemia.
Widgren BR; Urbanavicius V; Wikstrand J; Attvall S; Persson B
Am J Hypertens; 1993 Oct; 6(10):892-5. PubMed ID: 8267948
[TBL] [Abstract][Full Text] [Related]
28. Improvement of insulin sensitivity by metformin treatment does not lower blood pressure of nonobese insulin-resistant hypertensive patients with normal glucose tolerance.
Dorella M; Giusto M; Da Tos V; Campagnolo M; Palatini P; Rossi G; Ceolotto G; Felice M; Semplicini A; Del Prato S
J Clin Endocrinol Metab; 1996 Apr; 81(4):1568-74. PubMed ID: 8636369
[TBL] [Abstract][Full Text] [Related]
29. Effect of adrenergic-blocking or -stimulating agents on plasma growth hormone, immunoreactive insulin, and blood free fatty acid levels in man.
Imura H; Kato Y; Ikeda M; Morimoto M; Yawata M
J Clin Invest; 1971 May; 50(5):1069-79. PubMed ID: 4928263
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of beta- but not alpha 1-mediated adrenergic responses in isolated hearts and cardiomyocytes by nitric oxide and 8-bromo cyclic GMP.
Ebihara Y; Karmazyn M
Cardiovasc Res; 1996 Sep; 32(3):622-9. PubMed ID: 8881523
[TBL] [Abstract][Full Text] [Related]
31. Systolic blood pressure alterations during hyperinsulinemia are related to changes in ionized calcium status.
Haenni A; Fugmann A; Lind L; Lithell H
Am J Hypertens; 2001 Nov; 14(11 Pt 1):1106-11. PubMed ID: 11724208
[TBL] [Abstract][Full Text] [Related]
32. alpha1A-adrenoceptors activate glucose uptake in L6 muscle cells through a phospholipase C-, phosphatidylinositol-3 kinase-, and atypical protein kinase C-dependent pathway.
Hutchinson DS; Bengtsson T
Endocrinology; 2005 Feb; 146(2):901-12. PubMed ID: 15550506
[TBL] [Abstract][Full Text] [Related]
33. Neurovascular and hemodynamic responses to hyperinsulinemia in healthy postmenopausal women.
Cardoso CG; Sakai D; Pinto LG; Labes E; de Gusmão JL; Abrahão SB; Tinucci T; Mion D; da Fonseca AM; Forjaz CL
Maturitas; 2007 Sep; 58(1):50-8. PubMed ID: 17580104
[TBL] [Abstract][Full Text] [Related]
34. Ventromedial hypothalamus lesions increase the dipsogenic responses and reduce the pressor responses to median preoptic area activation.
Bastos R; Menani JV; Saad WA; Renzi A; Silveira JE; Camargo LA
Physiol Behav; 1997 Aug; 62(2):311-6. PubMed ID: 9251973
[TBL] [Abstract][Full Text] [Related]
35. Changes in blood pressure and plasma catecholamine levels during prolonged hyperinsulinemia.
Kern W; Peters A; Born J; Fehm HL; Schultes B
Metabolism; 2005 Mar; 54(3):391-6. PubMed ID: 15736119
[TBL] [Abstract][Full Text] [Related]
36. The effects of gender on adrenergic receptor responsiveness.
Luzier AB; Nawarskas JJ; Añonuevo J; Wilson MF; Kazierad DJ
J Clin Pharmacol; 1998 Jul; 38(7):618-24. PubMed ID: 9702846
[TBL] [Abstract][Full Text] [Related]
37. Seven days of euglycemic hyperinsulinemia induces insulin resistance for glucose metabolism but not hypertension, elevated catecholamine levels, or increased sodium retention in conscious normal rats.
Koopmans SJ; Ohman L; Haywood JR; Mandarino LJ; DeFronzo RA
Diabetes; 1997 Oct; 46(10):1572-8. PubMed ID: 9313752
[TBL] [Abstract][Full Text] [Related]
38. Circadian variation of alpha 1-adrenoceptor-mediated pressor response to phenylephrine in man.
Tham TC; Guy S; Riddell JG; Shanks RG; Harron DW
J Pharm Pharmacol; 1996 May; 48(5):526-8. PubMed ID: 8799880
[TBL] [Abstract][Full Text] [Related]
39. beta(2) and beta(3)-adrenoceptor inhibition of alpha(1)-adrenoceptor-stimulated Ca(2+) elevation in human cultured prostatic stromal cells.
Haynes JM
Eur J Pharmacol; 2007 Sep; 570(1-3):18-26. PubMed ID: 17617401
[TBL] [Abstract][Full Text] [Related]
40. Interaction of rapid nongenomic cardiovascular aldosterone effects with the adrenergic system.
Schmidt BM; Georgens AC; Martin N; Tillmann HC; Feuring M; Christ M; Wehling M
J Clin Endocrinol Metab; 2001 Feb; 86(2):761-7. PubMed ID: 11158043
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
